Althea Technologies' focus is on accelerating gene-based drug development by supporting researchers worldwide in their attempts to understand the mechanisms of disease and develop new therapeutics. The company's services include gene expression analyses using its proprietary eXpress Profiling technology, custom genomic analyses using real-time PCR, and cGMP plasmid DNA production for genetic vaccine and gene therapy products. For more information, visit www.altheatech.com.